HEALTH● LOWSep 22 · Sep 22, 2026, 10:52 AM
Roche GLP-1 delivers 16% weight loss in mid-stage trial
Seeking Alpha Tech · global
A mid-stage trial of Roche GLP-1 has shown that the drug delivers 16% weight loss. This indicates a promising development in pharmaceutical weight management.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH31m agoSuspected Fake Surgeon Arrested In Rivers State, Eight Facilities SealedChannels TVHEALTH34m agoMental health at work starts by breaking the taboo, EU agency saysEuroNews [en]HEALTH52m agoUCH resident doctors suspend warning strikeVanguard NigeriaHEALTH54m agoEssential items to stock in your medicine cabinet for cold and flu seasonNPR News